{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:31:08Z","timestamp":1760056268584,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003443","name":"Ministry of Education and Science of the Russian Federation","doi-asserted-by":"publisher","award":["AAAA-\u041021-121011490014-4","FSUS-2020-0035"],"award-info":[{"award-number":["AAAA-\u041021-121011490014-4","FSUS-2020-0035"]}],"id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jpba.2021.114062","type":"journal-article","created":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T12:43:12Z","timestamp":1617453792000},"page":"114062","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Biostability study, quantitation method and preliminary pharmacokinetics of a new antifilovirus agent based on borneol and 3-(piperidin-1-yl)propanoic acid"],"prefix":"10.1016","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3338-8529","authenticated-orcid":false,"given":"Artem D.","family":"Rogachev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina P.","family":"Putilova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna V.","family":"Zaykovskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga I.","family":"Yarovaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasiya S.","family":"Sokolova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1827-3309","authenticated-orcid":false,"given":"Vladislav V.","family":"Fomenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleg V.","family":"Pyankov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rinat A.","family":"Maksyutov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrey G.","family":"Pokrovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nariman F.","family":"Salakhutdinov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2021.114062_bib0005","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/nature06536","article-title":"Global trends in emerging infectious diseases","volume":"451","author":"Jones","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jpba.2021.114062_bib0010","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/00001888-200512000-00002","article-title":"Emerging and reemerging infectious diseases: the perpetual challenge","volume":"80","author":"Fauci","year":"2005","journal-title":"Acad. Med."},{"key":"10.1016\/j.jpba.2021.114062_bib0015","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1070\/RCR4969","article-title":"Mono- and sesquiterpenes as a starting platform for the development of antiviral drugs","volume":"90","author":"Yarovaya","year":"2021","journal-title":"Russ. Chem. Rev."},{"key":"10.1016\/j.jpba.2021.114062_bib0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.fct.2008.06.031","article-title":"Fragrance material review on borneol","volume":"46","author":"Bhatia","year":"2008","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.jpba.2021.114062_bib0025","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1080\/10717544.2018.1486471","article-title":"Borneol, a messenger agent, improves central nervous system drug delivery through enhancing blood\u2013brain barrier permeability: a preclinical systematic review and meta-analysis","volume":"25","author":"Zheng","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jpba.2021.114062_bib0030","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1742-7843.2011.00784.x","article-title":"Investigation of mechanisms involved in (-)-Borneol-induced vasorelaxant response on rat thoracic aorta","volume":"110","author":"Silva-Filho","year":"2011","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.jpba.2021.114062_bib0035","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.neuroscience.2010.11.029","article-title":"Protection by borneol on cortical neurons against oxygen-glucose deprivation\/reperfusion: involvement of anti-oxidation and anti-inflammation through nuclear transcription factor \u03baappaB signaling pathway","volume":"176","author":"Liu","year":"2011","journal-title":"Neurosci."},{"key":"10.1016\/j.jpba.2021.114062_bib0040","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.biopha.2017.09.122","article-title":"Ameliorative effect of borneol, a natural bicyclic monoterpene against hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic Wistar rats","volume":"96","author":"Madhuri","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jpba.2021.114062_bib0045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0166-3542(99)00036-4","article-title":"Antiviral properties of isoborneol, a potent inhibitor of herpes simplex virus type 1","volume":"43","author":"Armaka","year":"1999","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jpba.2021.114062_bib0050","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jchromb.2019.01.023","article-title":"Development and validation an LC-MS\/MS method to quantify (+)-borneol in rat plasma: Application to a pharmacokinetic study","volume":"1109","author":"Ren","year":"2019","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2021.114062_bib0055","unstructured":"O. I. Yarovaya, A. S. Sokolova, A. A. Kononova, S. V. Cheresiz, R. A. Nikitina, A. A. Chepurnov, A. V. Zaykovskaya, O. V. Pyankov, A. G. Pokrovsky, R. A. Maksyutov, N. F. Salakhutdinov, 3-N-substituted bornylpropionates used as Marburg virus inhibitors. RF Patent No. 2 649 406 (2018)."},{"key":"10.1016\/j.jpba.2021.114062_bib0060","unstructured":"O. I. Yarovaya, A. S. Sokolova, D. N. Shcherbakov, A. V. Zybkina, A. V. Zaykovskaya, O. V. Pyankov, R. A. Maksyutov, N. F. Salakhutdinov, 1,7,7-trimethylbicyclo [2.2.1] heptan-2-yl 3- (piperidin-1-yl) propionate hydrochloride used as an inhibitor of the Ebola virus. RF Patent No. 2 697 716 (2019)."},{"key":"10.1016\/j.jpba.2021.114062_bib0065","doi-asserted-by":"crossref","first-page":"112726","DOI":"10.1016\/j.ejmech.2020.112726","article-title":"Monoterpenoid-based inhibitors of filoviruses targeting the glycoprotein-mediated entry process","volume":"207","author":"Sokolova","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jpba.2021.114062_bib0070","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.201800153","article-title":"Discovery of a new class of inhibitors of vaccinia virus based on (\u2212)-borneol from Abies sibirica and (+)-camphor","volume":"15","author":"Sokolova","year":"2018","journal-title":"Chem. Biodiver."},{"key":"10.1016\/j.jpba.2021.114062_bib0075","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1039\/C6MD00657D","article-title":"Synthesis and in vitro study of novel borneol derivatives as potent inhibitors of the influenza A virus","volume":"8","author":"Sokolova","year":"2017","journal-title":"MedChemComm"},{"key":"10.1016\/j.jpba.2021.114062_bib0080","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s11172-018-2110-y","article-title":"Antiulcerogenic activity of borneol derivatives","volume":"67","author":"Borisova","year":"2018","journal-title":"Russ. Chem. Bull."},{"year":"2018","series-title":"Guidance for Industry: Bioanalytical Method Validation","key":"10.1016\/j.jpba.2021.114062_bib0085"},{"year":"2015","series-title":"Guideline on Bioanalytical Method Validation","key":"10.1016\/j.jpba.2021.114062_bib0090"},{"key":"10.1016\/j.jpba.2021.114062_bib0095","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jchromb.2016.08.039","article-title":"Simultaneous determination of curcumin diethyl disuccinate and its active metabolite curcumin in rat plasma by LC\u2013MS\/MS: application of esterase inhibitors in the stabilization of an ester-containing prodrug","volume":"1033-1034","author":"Na Bhuket","year":"2016","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2021.114062_bib0100","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.4155\/bio.14.43","article-title":"A simple and robust LC-MS\/MS method for measuring sirolimus and everolimus in whole blood","volume":"6","author":"Yuan","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2021.114062_bib0105","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/FTD.0000000000000586","article-title":"Rapid quantitation of flecainide in human plasma for therapeutic drug monitoring using liquid chromatography and time-of-flight mass spectrometry","volume":"41","author":"Rahman","year":"2019","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2021.114062_bib0110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.chroma.2015.02.008","article-title":"Simultaneous determination of eperisone hydrochloride and paracetamol in mouse plasma by high performance liquid chromatography-photodiode array detector","volume":"1388","author":"Locatelli","year":"2015","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2021.114062_bib0115","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1023\/A:1016259826037","article-title":"Species dependent esterase activities for hydrolysis of an anti-HIV prodrug glycovir and bioavailability of active SC-48334","volume":"12","author":"Cook","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jpba.2021.114062_bib0120","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1248\/bpb.28.1126","article-title":"Stability of spironolactone in rat plasma: strict temperature control of blood and plasma samples is required in rat pharmacokinetic studies","volume":"28","author":"Tokumura","year":"2005","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jpba.2021.114062_bib0125","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jpba.2009.09.023","article-title":"Improving the ex vivo stability of drug ester compounds in rat and dog serum: inhibition of the specific esterases and implications on their identity","volume":"51","author":"Koitka","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2021.114062_bib0130","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/jps.20542","article-title":"Enzymes involved in the bioconversion of ester-based prodrugs","volume":"95","author":"Liederer","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2021.114062_bib0135","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/bmc.1572","article-title":"Strategies in quantitative LC-MS\/MS analysis of unstable small molecules in biological matrices","volume":"25","author":"Li","year":"2011","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpba.2021.114062_bib0140","doi-asserted-by":"crossref","first-page":"733","DOI":"10.4155\/bio.10.30","article-title":"Effective screening approach to select esterase inhibitors used for stabilizing ester-containing prodrugs analyzed by LC\u2013MS\/MS","volume":"2","author":"Fung","year":"2010","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2021.114062_bib0145","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3109\/00498254.2011.573016","article-title":"In vitro stability and metabolism of O2\u2032, O3\u2032, O5\u2032-tri-acetyl-N6-(3-hydroxylaniline) adenosine in rat, dog and human plasma: chemical hydrolysis and role of plasma esterases","volume":"41","author":"Liu","year":"2010","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jpba.2021.114062_bib0150","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/00498250902769967","article-title":"In vitro stability and metabolism of salvinorin A in rat plasma","volume":"39","author":"Tsujikawa","year":"2009","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jpba.2021.114062_bib0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2020.122448","article-title":"Development and validation of samples stabilization strategy and LC-MS\/MS method for simultaneous determination of clevidipine and its primary metabolite in human plasma: application to clinical pharmacokinetic study in Chinese healthy volunteers","volume":"1161","author":"Zhang","year":"2020","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2021.114062_bib0160","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4155\/bio.12.294","article-title":"Heat stabilization of blood spot samples for determination of metabolically unstable drug compounds","volume":"5","author":"Blessborn","year":"2012","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2021.114062_bib0165","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2165\/00003088-200241100-00005","article-title":"Enterohepatic circulation","volume":"41","author":"Roberts","year":"2002","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jpba.2021.114062_bib0170","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1039\/C8RA08594C","article-title":"Interspecies differences in stability kinetics and plasma esterases involved in hydrolytic activation of curcumin diethyl disuccinate, a prodrug of curcumin","volume":"9","author":"Ratnatilaka Na Bhuket","year":"2019","journal-title":"RSC Adv."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708521001734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708521001734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:12:19Z","timestamp":1760001139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708521001734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":34,"alternative-id":["S0731708521001734"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2021.114062","relation":{},"ISSN":["0731-7085"],"issn-type":[{"type":"print","value":"0731-7085"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biostability study, quantitation method and preliminary pharmacokinetics of a new antifilovirus agent based on borneol and 3-(piperidin-1-yl)propanoic acid","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2021.114062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114062"}}